Biomerica, Inc. (BMRA)

Biomerica Statistics

Total Valuation

Biomerica has a market cap or net worth of $7.43 million. The enterprise value is $4.75 million.

Market Cap	7.43M
Enterprise Value	4.75M

Important Dates

The next estimated earnings date is Tuesday, January 13, 2026, after market close.

Earnings Date	Jan 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Biomerica has 2.95 million shares outstanding. The number of shares has increased by 15.58% in one year.

Current Share Class	2.95M
Shares Outstanding	2.95M
Shares Change (YoY)	+15.58%
Shares Change (QoQ)	+19.57%
Owned by Insiders (%)	10.02%
Owned by Institutions (%)	3.01%
Float	2.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.25
Forward PS	n/a
PB Ratio	1.38
P/TBV Ratio	1.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.97
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.07.

Current Ratio	3.48
Quick Ratio	2.52
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.61% and return on invested capital (ROIC) is -52.75%.

Return on Equity (ROE)	-69.61%
Return on Assets (ROA)	-41.49%
Return on Invested Capital (ROIC)	-52.75%
Return on Capital Employed (ROCE)	-94.69%
Revenue Per Employee	$90,444
Profits Per Employee	-$67,685
Employee Count	54
Asset Turnover	0.66
Inventory Turnover	2.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.15% in the last 52 weeks. The beta is 0.11, so Biomerica's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	+3.15%
50-Day Moving Average	2.52
200-Day Moving Average	3.21
Relative Strength Index (RSI)	51.35
Average Volume (20 Days)	147,490

Short Selling Information

The latest short interest is 41,348, so 1.40% of the outstanding shares have been sold short.

Short Interest	41,348
Short Previous Month	29,633
Short % of Shares Out	1.40%
Short % of Float	1.56%
Short Ratio (days to cover)	0.16

Income Statement

In the last 12 months, Biomerica had revenue of $4.88 million and -$3.66 million in losses. Loss per share was -$1.50.

Revenue	4.88M
Gross Profit	633,000
Operating Income	-4.89M
Pretax Income	-3.66M
Net Income	-3.66M
EBITDA	-4.80M
EBIT	-4.89M
Loss Per Share	-$1.50

Balance Sheet

The company has $3.05 million in cash and $373,000 in debt, giving a net cash position of $2.68 million or $0.91 per share.

Cash & Cash Equivalents	3.05M
Total Debt	373,000
Net Cash	2.68M
Net Cash Per Share	$0.91
Equity (Book Value)	5.16M
Book Value Per Share	1.83
Working Capital	4.21M

Cash Flow

Operating Cash Flow	-2.77M
Capital Expenditures	n/a
Free Cash Flow	-2.77M
FCF Per Share	-$0.94

Margins

Gross margin is 12.96%, with operating and profit margins of -100.06% and -74.84%.

Gross Margin	12.96%
Operating Margin	-100.06%
Pretax Margin	-74.84%
Profit Margin	-74.84%
EBITDA Margin	-98.30%
EBIT Margin	-100.06%
FCF Margin	n/a

Dividends & Yields

Biomerica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.58%
Shareholder Yield	-15.58%
Earnings Yield	-49.20%
FCF Yield	-37.22%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 21, 2025. It was a reverse split with a ratio of 1:8.

Last Split Date	Apr 21, 2025
Split Type	Reverse
Split Ratio	1:8

Scores

Biomerica has an Altman Z-Score of -8.85 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.85
Piotroski F-Score	4